1. Introduction {#sec1-1}
===============

Although hazards of laser are well known, laser injuries continue to occur. Laser-induced retinal injury can occur from clinical, industrial, military, and recreational lasers.[@ref1] The commonly used Q-switched Nd:YAG laser is involved due to failure to follow standard laser safety precautions.[@ref1] Q-switched Nd:YAG laser is particularly harmful as it is designed to emit short pulses of high energy in durations of few to tens of nanoseconds and can deliver an invisible dose of energy very rapidly to the retina.[@ref1] Nd:YAG laser-induced macular hole injury has been previously reported,[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8] but there are few previous case reports that have noted successful repair and recovery of vision following pars plana vitrectomy.[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7] Herein, we report a case of 21-year-old female who developed a large, full-thickness macular hole (FTMH) after inadvertent Nd:YAG laser exposure and who underwent successful surgical closure of the hole but did not regain full visual acuity. We also review the literature of surgically repaired, Nd:YAG laser-induced FTMHs and discuss clinical and imaging features that affect visual outcomes.

2. Case Report {#sec1-2}
==============

A 21-year-old female college student with no previous eye disease except mild myopia reported that she entered a room with a functioning laser without wearing eye protection. She reported that she was inadvertently exposed to a Q-switched Nd:YAG laser while not looking directly at the laser. The laser had a wavelength of 1064 nm, was firing at a rate of 1 Hz, pulse energy of 30--40 millijoules (mJ), duration of 7 nanoseconds, and beam width of 5 mm. She reported that the laser was being used for laser-induced breakdown spectroscopy and that she was 7 feet from the active laser. She reported that she immediately left the room, but after exiting, she noticed a single floater, which later developed into multiple floaters.

The floaters lasted for 4 days after which she noted a central scotoma. Two weeks after the incident, her best-corrected visual acuity (BCVA) was Snellen 20/80 in the left eye (OS) and 20/20 in the right eye (OD). There was no afferent pupillary defect. Clinical examination revealed a normal anterior segment in both eyes. Fundus examination and imaging OD were normal. Fundus examination OS demonstrated an FTMH, with whitish coagulative debris in the depths of the hole, and a stream of mild vitreous hemorrhage emanating from the hole and settling inferiorly. The posterior hyaloid was not separated ([Figure 1](#F1){ref-type="fig"}A). Imaging including spectral-domain optical coherence tomography (SD-OCT; Cirrus, Carl Zeiss Meditech Inc., Dublin, CA, USA) identified an 800 μm FTMH with hemorrhagic hyperreflective debris within the cavity ([Figure 1](#F1){ref-type="fig"}B). After fully discussing the risks and benefits of macular surgery versus observation, surgical intervention was deferred by the patient. The patient returned 1 month later, at which time her vision had dropped to 20/400. Clinical examination and fundus imaging remained unchanged. The patient was advised to undergo surgical repair, but she elected to defer the surgery until completion of her academic year.

![Fundus photo of the left eye (A) on initial presentation demonstrating a full-thickness macular hole (FTMH) with a white discoloration of the retinal pigment epithelium, pigmented granules at the base and surrounding subretinal fluid. (B) Spectral-domain optical coherence tomography demonstrates hemorrhagic hyperreflective foci within the cavity of the hole, an FTMH measuring 800 μm at the innermost diameter, cystoid macular edema in the inner and outer nuclear layers, and disruption of the adjacent ellipsoid zones.](TJO-6-195-g001){#F1}

Subsequently, 4 months after the initial injury, the patient underwent pars plana vitrectomy with separation of the posterior hyaloid, brilliant blue assisted internal limiting membrane peeling, autologous plasma and thrombin placement,[@ref9] and injection with 15% hexafluoroethane (C~2~F~6~) gas with postoperative prone positioning for 2 weeks. At her postoperative visit 10 weeks following her procedure, clinical examination demonstrated a closed macular hole with BCVA 20/150. Fundus imaging, including SD-OCT, showed a closed FTMH with persistent defects in her outer retinal layers including the ellipsoid and external limiting membrane (Figure [2](#F2){ref-type="fig"}A and 2B). At her last office visit, 19 months after the surgery, the FTMH was closed, and her BCVA remained 20/150.

![Fundus photo of the left eye (A) 10 weeks following surgical repair of the Nd:YAG laser-induced full-thickness macular hole (FTMH) demonstrating a closed hole with central focal pigmentation and surrounding atrophy. Spectral domain optical coherence tomography (B) shows a closed FTMH with persistent defects in her outer retinal layers including the ellipsoid and external limiting membrane. There is retinal pigment epithelial atrophy with increased transmission to the choroid.](TJO-6-195-g002){#F2}

3. Discussion {#sec1-3}
=============

Despite numerous regulations to ensure laser safety, accidents still occur in the most well informed populations. This injury was particularly severe due to the power of the laser involved. Studies have shown that the damage to the retina and the visual prognosis depended on the energy delivered and the proximity of the injury to the fovea.[@ref1] Experiments in human and animal eyes have demonstrated that 1--3 mJ of Nd:YAG laser energy can cause variable amounts of retinal damage, including macular hole formation.[@ref1][@ref10] In this case, the patient was exposed to an invisible pulse of laser that likely reflected off of a metallic laser target. However, even a fraction of the 20--30 mJ was more than sufficient to cause an FTMH.

Initially, the Nd:YAG energy is absorbed by melanin located in the retinal pigment epithelium (RPE) and creates tissue ionization, plasma formation, and an acoustic shock wave that spread centrifugally leading to mechanical disruption of the surrounding retina, RPE, and choroid.[@ref1][@ref2] Over time, the initial injury causes a release of inflammatory mediators from the directly damaged cells that lead to collateral damage to neighboring cells.[@ref1] Late complications include chorioretinal scarring and neovascularization, macular cyst, macular pucker, and FTMH.[@ref1] Some FTMHs may close spontaneously,[@ref8] but most cases require surgical repair.[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7] The pathophysiologic mechanism of a laser-induced FTMH differs from an idiopathic FTMH, which is related to the tractional forces created by an anomalous posterior vitreous detachment.[@ref4][@ref8] In laser-induced cases, the posterior hyaloid is still partially attached with a localized detachment over the FTMH, but tractional forces may develop due to disruption of retinal tissue and retinal fibroglial formation.[@ref8] Spontaneous closure of laser-induced holes may relate to small initial hole size and the presence of hemorrhage that may act as tissue glue.[@ref8]

In this case, the FTMH formation may have been due to a combination of mechanical and thermal damage. Had the injury occurred in a controlled manner with this Q-switched Nd:YAG laser, the damage mechanism would have certainly been optical breakdown within the retinal tissue. However, the OCT image suggests a thermal component to the injury. The loss of tissue seen at the center of the macula suggests optical breakdown, while the white, hyperreflective mass at the base of the hole and the patient\'s history suggest thermal damage. It is possible that she did not notice a central scotoma until a few days after the injury, at which time thermal damage led to the development of tractional forces, due to disruption of retinal tissue and retinal fibroglial formation,[@ref8] and enlarged the hole leading to the functional central scotoma. Perhaps the hemorrhagic floaters also distracted her from noticing the initial scotoma.

There are few reports of vitrectomy to close an FTMH after Nd:YAG laser exposure. Given the rarity of these reports, the factors that contribute to visual recovery remain unclear. A literature review ([Table 1](#T1){ref-type="table"}) of similar cases was performed. Including our patient, all seven eyes achieved anatomical closure of the FTMH, although one case required repeat vitrectomy combined with internal limiting membrane peeling.[@ref5] Some authors have reported excellent visual acuity,[@ref2][@ref3][@ref4][@ref5][@ref6] while others, including our case, achieved hole closure with a modest improvement in visual acuity.[@ref7] Reviewing the preoperative data and surgical techniques ([Table 1](#T1){ref-type="table"}), the time to initial surgery seemed to be different between the two groups with a range of 10 days to 2 months in the good final BCVA cases and a range of 4--5 months in the poor final BCVA cases. Both the case reported by Gao and associates[@ref7] and this case showed severe thinning and loss of the entire outer photoreceptor bands including the ellipsoid and external limiting membrane and retinal pigment epithelial layer. These OCT findings may explain the poor postoperative BCVA in these cases. Statistical analysis of these cases is limited by the few reports of surgically-repaired, Nd:YAG-induced FTMH, as well as the fact that the review of the literature is a collection of case reports without continuity. Given this limitation, an extended interval between injury and surgical repair and persistent postoperative damage to the outer retinal structures appear to be poor prognostic features for visual recovery.

###### 

Summary of reported surgically repaired full-thickness macular holes secondary to Nd:YAG laser exposure.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author; study year                     Patient age (y); gender; eye   Energy; interval    BCVA prior to surgery   Size of hole prior to surgery (jim)   Time to initial surgery (mo)   Hemorrhage present   Surrounding macular hole CME   Surgical ILM peeled   Dye used   Autologous serum   Gas used       Last exam BCVA   Postoperative OCT and intact ELM and ellipsoid   Follow-up duration (mo)
  -------------------------------------- ------------------------------ ------------------- ----------------------- ------------------------------------- ------------------------------ -------------------- ------------------------------ --------------------- ---------- ------------------ -------------- ---------------- ------------------------------------------------ -------------------------
  Current case                           21, Female; OS                 30-40 mj;           20/400                  N: 800                                4.0                            Yes                  Yes                            Yes                   BB         Yes                15% C~2~F~6~   20/150           SD-OCT; none                                     19.0

  Fernandez et al[@ref2]; 2013           11, Male; OD                   7 ns 50 mj; 8 ns    20/100                  B: 1077                               2.0                            No                   Yes                            Yes                   ICG        No                 18% C~3~F~s~   20/25            SD-OCT; ELM                                      3.0

  Sou et al[@ref3]; 2003                 33, Male; OD                   100-500 mj; 10 ns   20/30                   N: 117                                1.0                            Yes                  Yes                            Yes                   N/A        No                 20% SF~6~      20/20            TD-OCT; both                                     12.0

  Potthofer and Foerster [@ref4]; 1997   30; Male; OS                   N/A                 20/100                  N: 300                                1.5                            Yes                  N/A                            No                    N/A        Yes                30%\           20/32            N/A                                              9.0
                                                                                                                                                                                                                                                                                                 SF~6~                                                                            

  Ben-Simon et al[@ref5]; 2003           35, Male, OS                   N/A                 20/100                  N/A                                   0.33 (10 d)                    Yes                  N/A                            No                    No         No                 16% C~3~F~s~   20/140           N/A                                              1.75

                                         OS repeat PPV                                      20/200                  N/A                                   8.75                           No                   N/A                            Yes                   ICG        No                 16% C~3~F~s~   20/60            N/A                                              3.0

  Chen[@ref6]; 2010                      31, Male; OS                   10 mj; 5-20 ns      20/60                   N: 820                                1.0                            Yes                  Yes                            Yes                   ICG        No                 16% C~3~F~s~   20/20            TD-OCT; both                                     12.0

  Gao et a[@ref7]; 2007                  36, Male; OD                   500 mj, 8 ms        20/200                  N: 700                                5.0                            Yes                  Yes                            Yes                   N/A        No                 18% C~2~F~6~   20/200           TD-OCT; none                                     13.0
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

B = base diameter of the macular hole; BB =brilliant blue dye; BCVA= best-corrected visual acuity; CME = cystoid macular edema; ELM = external limiting membrane; ICG =indocyanine green; ILM= internal limiting membrane; mJ = millijoules; N = narrowest diameter of the macular hole; N/A= not available; ns=nanoseconds; OCT=optical coherence tomography; OD=right eye; OS= left eye; PPV= pars plana vitrectomy; SD= spectraldomain; TD = time-domain.

Although this report and analysis focuses on Nd:YAG-induced macular holes, many types of lasers have been reported to cause retinal damage and macular holes. In particular, retinal damage caused by inexpensive and powerful handheld lasers has been described. Alsulaiman and colleagues[@ref11] reviewed 17 cases of laser-induced macular holes caused by handheld blue lasers. Similar to our findings, they concluded that early vitrectomy was beneficial, and disruption in the ellipsoid layer on SD-OCT reduced visual improvement.

This report of an accidental laser injury underscores the need to educate on and emphasize eye safety procedures to those using lasers. This is particularly important for powerful Q-switched Nd:YAG lasers in industrial and academic settings. Vitrectomy is a successful therapy for laser-induced macular hole. The efficacy of this procedure in other reports and in our case strongly suggests that one should perform early vitrectomy in these cases. However, the final visual outcome may be determined by the severity and location of the injury to the macula.
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